Recently, in a neurodegenerative/neuroinflammatory disorder such as Alzheimer’s disease, it has been demonstrated that activated microglia are recruited to the site of injury via ChemR23 activation [22,23]. This evidence concerns the gene CMKLR1 and early-onset autosomal dominant Alzheimer disease.